Last reviewed · How we verify
NCT03645538
Analysis of Cortical Biomarkers for PD
trial testing Parkinson's disease patients in Parkinson Disease in 20 participants. Status unknown.
30 January 2019
Quick facts
| Lead sponsor | Universidade Federal de Pernambuco |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 September 2018 |
| Primary completion | 30 January 2019 |
| Estimated completion | 30 January 2020 |
| Sites | 2 locations across Brazil |
Drugs / interventions tested
- Parkinson's disease patients
- No drug — full drug profile →
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Healthy — all drugs for Healthy →
Sponsor
Universidade Federal de Pernambuco — full company profile →
Who can join
Adults 40 to 80, any sex, with Parkinson Disease or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Previous studies revealed changes in the pattern of cortical electrical activity of patients with Parkinson's disease (PD) and suggested that these changes may be dependent on the phenotypes of the disease and other related factors. A greater understanding of cortical electrical activity in PD patients may be relevant to guide professionals about the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). The present study aims to evaluate the pattern of brain activity of PD patients and to correlate the findings with the disease phenotypes and with other clinical characteristics. For this, volunteers with PD and healthy will participate in a single experimental session in which behavioral and electrophysiological assessments will be performed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03645538
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Universidade Federal de Pernambuco trials
Trials by the same sponsor.
- NCT07366411 — taVNS on Functional Mobility in People With DP · Phase 2 · not yet recruiting
- NCT07132021 — Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity Motor Recovery in Stroke Survivors · Phase 2 · recruiting
- NCT07149233 — Effectiveness of Inspiratory Muscle Training on Sleep in Patients With Obstructive Sleep Apnea · NA · enrolling by invitation
- NCT06886386 — TsDCS and Physical Therapy After Incomplete Spinal Cord Injury · NA · enrolling by invitation
- NCT07523126 — EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03645538 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Pernambuco
- Last refreshed: 24 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03645538.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing